KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Other Non-Current Assets (2019 - 2026)

GoodRx Holdings' Other Non-Current Assets history spans 7 years, with the latest figure at $29.1 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 23.7% to $29.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.1 million, a 23.7% increase, with the full-year FY2025 number at $29.1 million, up 23.7% from a year prior.
  • Other Non-Current Assets hit $29.1 million in Q4 2025 for GoodRx Holdings, up from $23.3 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for GDRX hit a ceiling of $44.5 million in Q2 2023 and a floor of $2.2 million in Q1 2021.
  • Historically, Other Non-Current Assets has averaged $26.1 million across 5 years, with a median of $26.6 million in 2022.
  • Biggest five-year swings in Other Non-Current Assets: surged 1603.9% in 2022 and later crashed 37.92% in 2025.
  • Tracing GDRX's Other Non-Current Assets over 5 years: stood at $6.0 million in 2021, then surged by 352.22% to $27.2 million in 2022, then soared by 39.06% to $37.8 million in 2023, then tumbled by 37.74% to $23.5 million in 2024, then increased by 23.7% to $29.1 million in 2025.
  • Business Quant data shows Other Non-Current Assets for GDRX at $29.1 million in Q4 2025, $23.3 million in Q3 2025, and $23.9 million in Q2 2025.